ProjectPTC Vatiquinone FA – A randomized, parallel-arm, double-blind, placebo-controlled Study with open-label extension…
Basic data
Acronym:
PTC Vatiquinone FA
Title:
A randomized, parallel-arm, double-blind, placebo-controlled Study with open-label extension to assess the safety and efficacy of Vatiquinone for the treatment of Friedreich Ataxia
Duration:
01/03/2021 to 28/02/2023
Abstract / short description:
A randomized, parallel-arm, double-blind, placebo-controlled Study with open-label extension to assess the safety and efficacy of Vatiquinone for the treatment of Friedreich Ataxia
Keywords:
Vatiquinone
Friedreich Ataxie
Ataxie
kontrollierte Studie
Phase 3 Studie
PTC
Involved staff
Managers
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Local organizational units
Department of Neurology with Focus on Neurodegenerative Disorders
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Funders
Plainfield, New Jersey, United States